Genome Editing 3 – How do I participate and what is the role of patient organizations - Video
This four-part Genome Editing series was created in 2020. In December 2023, FDA issued its first approval of a product using genome editing technology.
Your Support Keeps Rare Disease Resources Free
Every day matters for patients, researchers, and families who rely on NORD's trusted information.
We can’t keep these resources free and growing without your help.
Please donate today — and power the future of rare disease progress.
Whether you’re a patient, researcher, student, or advocate — we’re here for you.
If you’ve found NORD’s resources helpful, please consider donating.
Your support keeps this information free, updated, and available for everyone who needs it.
